Evidence map›Paper›PMID 34439755›Full record

ArticleBiomolecules2021

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs.

Marta Poźniak, Weronika Zarzycka, Natalia Porębska, Agata Knapik, Paulina Marczakiewicz-Perera, Malgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marta PoźniakDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
Weronika ZarzyckaDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
Natalia PorębskaDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
Agata KnapikDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
Paulina Marczakiewicz-PereraDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
Malgorzata ZakrzewskaDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.ORCID 0000-0001-8214-1533
Jacek OtlewskiDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.ORCID 0000-0001-8630-2891
Łukasz OpalińskiDepartment of Protein Engineering, Faculty of Biotechnology, University of Wrocław, 50-387 Wrocław, Poland.
University of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FGFRs are cell surface receptors that, when activated by specific FGFs ligands, transmit signals through the plasma membrane, regulating key cellular processes such as differentiation, division, motility, metabolism and death. We have recently shown that the modulation of the spatial distribution of FGFR1 at the cell surface constitutes an additional mechanism for fine-tuning cellular signaling. Depending on the multivalent, engineered ligand used, the clustering of FGFR1 into diverse supramolecular complexes enhances the efficiency and modifies the mechanism of receptor endocytosis, alters FGFR1 lifetime and modifies receptor signaling, ultimately determining cell fate. Here, we present a novel approach to generate multivalent FGFR1 ligands. We functionalized FGF1 for controlled oligomerization by developing N- and C-terminal fusions of FGF1 with the Fc fragment of human IgG1 (FGF1-Fc and Fc-FGF1). As oligomerization scaffolds, we employed GFPpolygons, engineered GFP variants capable of well-ordered multivalent display, fused to protein G to ensure binding of Fc fragment. The presented strategy allows efficient assembly of oligomeric FGFR1 ligands with up to twelve receptor binding sites. We show that multivalent FGFR1 ligands are biologically active and trigger receptor clustering on the cell surface. Importantly, the approach described in this study can be easily adapted to oligomerize alternative growth factors to control the activity of other cell surface receptors.

Indexed as

AnimalsBinding SitesCell Line, TumorCluster AnalysisEndocytosisEndosomesFibroblast Growth Factor 1Green Fluorescent ProteinsHumansImmunoglobulin GLigandsMiceMicroscopy, FluorescenceNIH 3T3 CellsPhosphorylationProtein BindingFGFR1 protein, humanFgfr1 protein, mouseFibroblast Growth Factor 1Green Fluorescent ProteinsImmunoglobulin GLigandsReceptor, Fibroblast Growth Factor, Type 1Recombinant ProteinsendocytosisFGF1FGFRsignalingspatial distribution

Identifiers

PMID34439755
PMCPMC8392455
OpenAlexW3184104396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.